Jane Street
XGN icon

Jane Street’s Exagen XGN Stock Holding History

Jane Street’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$710K Buy
236,735
+42,699
+22% +$165K ﹤0.01% 7252
2025
Q4 		$1.18M Buy
194,036
+91,729
+90% +$835K ﹤0.01% 5797
2025
Q3 		$1.12M Buy
+102,307
New +$906K ﹤0.01% 6072

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Jane Street's XGN Position: Q1 2026 in Review

Jane Street increased its Exagen (XGN) stake by 22% in Q1 2026, buying an estimated $165K and bringing the position to 236,735 shares worth $710K. The position accounts for ﹤0.01% of the portfolio, ranked #7252.

Jane Street first reported a position in XGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.18M in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Jane Street held 236,735 shares of Exagen worth $710K as of Q1 2026.
  • Jane Street bought 42,699 Exagen shares in Q1 2026, an estimated $165K.
  • Exagen made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7252 holding.
  • Jane Street first reported a position in Exagen in Q3 2025 and has held it in 3 quarters since.
  • Jane Street's Exagen position peaked at $1.18M in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.